Can I read Aurobindo Pharma Q3FY18 Financial Update on EtoBox?

Aurobindo Pharma Q3FY18 Financial Update by shubham nehe is a document available to read on EtoBox.

What is Aurobindo Pharma Q3FY18 Financial Update about?

Aurobindo Pharma reported continued sales, adjusted EBITDA, and PAT growth despite declining revenue from Renvela due to competition. Its US injectables business grew sequentially but missed targets due to approval delays. Emerging market sales grew 15% quarter-over-quarter and are guided to grow 15-20% in FY19. The company

Author

shubham nehe

Language

EN